Skip to main content
Clinical Trials/CTRI/2025/04/085198
CTRI/2025/04/085198Not yet recruitingPhase 1

A New Topical Drug Formulation With Methanol Extract Of CASSIA AURICULATA WITH ALPHA TOCOPHEROL AND POVIDON IODINE VS REGULAR dressing solution for foot ulcer patients

Saveetha medical college and hospital1 site in 1 country50 target enrollmentStarted: April 27, 2025Last updated:

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor
Enrollment
50
Locations
1
Primary Endpoint
The effectiveness of new topical solution in promoting wound healing

Study Overview

Brief Summary

This study provides compelling evidence supporting the use of a herbal-based wound dressing as a viable alternative to conventional synthetic wound care solutions. The formulation, enriched with Cassia auriculata extract, alpha-tocopherol, and povidone-iodine, effectively addresses key challenges in wound healing, including infection control, inflammation modulation, and tissue regeneration.With further optimization to enhance its efficacy—particularly against resistant microbial strains—and rigorous clinical validation, this herbal-based intervention has the potential to revolutionize modern wound care. By integrating scientific advancements with traditional herbal medicine, this formulation offers an effective, natural, and safe alternative for wound healing, paving the way for sustainable and innovative therapeutic solutions in healthcare.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Healthy individuals.

Exclusion Criteria

  • Pregnancy Coronary artery disease.

Outcomes

Primary Outcomes

The effectiveness of new topical solution in promoting wound healing

Time Frame: Day 0,day 3,day 5,day 7

Secondary Outcomes

  • Evaluate efficacy of methanol extract of Cassia auriculata with povidone iodine & alpha tocopherol(Day 0,3,5,7)

Investigators

Sponsor
Saveetha medical college and hospital
Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

Sri Siva Shyla

Saveetha medical college and hospital

Study Sites (1)

Loading locations...

Similar Trials